GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_616/2025

GlaxoSmithKline Biologicals SA v. Moderna et al

Datum
2026-02-18
Kammer
The Hague (NL) Local Division
Verfahrensart
Infringement Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_616-2025-4f5d628f185f
Aktenzeichen
RegisterzeichenUPC_CFI_616/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

1 The Hague - Local Division UPC_CFI_616/2025 UPC_CFI_1439/2025 Order of the Court of First Instance of the Unified Patent Court delivered on 18/02/2026 regarding R.263 and R.9 RoP CLAIMANT 1) GlaxoSmithKline Biologicals SA (Claimant) - Rue de l'Institut 89 - 1330 - Rixensart – BE, “Claimant” or “GSK” Represented by Tjibbe Douma and others DEFENDANTS 1) Moderna Netherlands B.V. (Defendant) - Claude Debussylaan 7 - 1082 MC - Amsterdam - NL 2) Moderna Biotech Spain, S.L. (Defendant) - C/Julián Camarillo 31 - 28037 - Madrid - ES 3) Moderna Biotech UK Limited (Defendant) - 54 Portland Place - W1B 1DY - London - GB 2 4) Moderna Biotech Distributor UK Ltd (Defendant) - MYO, 123 Victoria Street - SW1E 6DE - London - GB 5) Moderna Switzerland GmbH (Defendant) - Peter Merian-Weg 10 - 4052 - Basel - ...